Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone could become a game-changing treatment for male-pattern hair loss. The ...
Seeking Alpha: Cosmo Announces Breakthrough Phase III Topline Results from Scalp 1 and Scalp 2 for Clascoterone 5% Solution in Male Hair Loss, Showing up to 539% Relative Improvement in ...
Cosmo Announces Breakthrough Phase III Topline Results from Scalp 1 and Scalp 2 for Clascoterone 5% Solution in Male Hair Loss, Showing up to 539% Relative Improvement in ...
Reuters on MSN: Cosmo Pharma's male hair loss treatment shows sustained hair growth in year‑long study
By Sneha S K and Sahil Pandey April 15 (Reuters) - Cosmo Pharmaceuticals said on Wednesday its experimental hair loss treatment showed sustained hair growth and long-term safety in men with common ...
Cosmo Pharma's male hair loss treatment shows sustained hair growth in year‑long study
New York Post on MSN: A topical acne drug might be the next big thing in treating hair loss
A topical acne drug might be the next big thing in treating hair loss
Yahoo Finance: Phase III 12-Month Data for Clascoterone 5% Topical Solution Confirm Positive Safety for Chronic Use and Continued Hair Growth, both of which are Statistically Significant
Phase III 12-Month Data for Clascoterone 5% Topical Solution Confirm Positive Safety for Chronic Use and Continued Hair Growth, both of which are Statistically Significant
Learn which medications maycause hair loss—including retinoids, antidepressants, blood thinners, and more—and what treatment options may help regrowth.
FiercePharma: Cosmo shares zoom with results from 2 male-pattern hair loss trials